KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Costar (CSGP) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Costar (CSGP) over the last 17 years, with Q3 2025 value amounting to $9.0 million.

  • Costar's Asset Writedowns and Impairment rose 227.27% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.5 million, marking a year-over-year increase of 398.86%. This contributed to the annual value of $36.4 million for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, Costar's Asset Writedowns and Impairment stood at $9.0 million, which was up 227.27% from $7.5 million recorded in Q2 2025.
  • Costar's 5-year Asset Writedowns and Impairment high stood at $11.8 million for Q3 2023, and its period low was $1.7 million during Q3 2021.
  • Over the past 5 years, Costar's median Asset Writedowns and Impairment value was $7.5 million (recorded in 2025), while the average stood at $6.7 million.
  • As far as peak fluctuations go, Costar's Asset Writedowns and Impairment plummeted by 7056.45% in 2021, and later soared by 28445.35% in 2022.
  • Quarter analysis of 5 years shows Costar's Asset Writedowns and Impairment stood at $3.1 million in 2021, then soared by 55.72% to $4.8 million in 2022, then soared by 92.47% to $9.3 million in 2023, then grew by 13.98% to $10.6 million in 2024, then decreased by 15.09% to $9.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $9.0 million for Q3 2025, versus $7.5 million for Q2 2025 and $9.4 million for Q1 2025.